Boeing's shares opened the year at $257.50. Regardless, Boeing has struggled to produce close to its maximum-allowed 737 planes per month due to supply-chain problems, quality issues and a seven-week-long strike that temporarily shut down most of its commercial aircraft production, including the 737 program. Boeing also continued to post massive losses from its commercial, military and space programs throughout the year.
A jumbo MMA may pay a higher interest rate in exchange for a higher balance. So where can you find the best jumbo money market rates? And are they worth it?
Stocks like Tesla and Nvidia now make up a huge chunk of the S&P 500's total value, exposing investors to heavy losses if they tumble.
US home prices rose to fresh record levels in October, though annual price growth decelerated, S&P G
(Bloomberg) -- Westchester County plans to issue roughly $189 million in general obligation bonds, with Fitch Ratings giving the debt a top-tier AAA rating. Most Read from BloombergDetroit’s Michigan Central Is the Building Revival Story of 2024Burned Out Parents Need Better Public SpacesMigrant Crisis Pushed US Homelessness to Record High in 2024The affluent enclave, home to New York City suburbs like Scarsdale and Rye, will use the proceeds from the sale expected in February for various capita
Warner Bros Discovery stock boasts the best average return of any SPX stock in January
Kazia Therapeutics Limited (NASDAQ:KZIA) stock is trading lower on Tuesday after the company provided a regulatory update on paxalisib for glioblastoma (GBM) following its Type C clinical meeting with the FDA. In July 2024, the company reported topline results from the GBM-AGILE study in which newly diagnosed unmethylated patients with glioblastoma treated with paxalisib showed a clinically meaningful improvement in a prespecified secondary analysis for overall survival (OS) compared to standard
A British car battery company led by former Tesla executives has quit the London stock market less than a month after tapping investors for £500,000.
Here's why this tech investor thinks Intel has a lot of proving to do.
Sangamo Therapeutics' (SGMO) shares were sinking intraday Tuesday after the company said its partner